Trial intelligence / Profile preview

Esmolol in Patients With Sepsis

NCT04537767Unknown

Sponsor
Zhongshan Hospital, Fudan University
Start
Oct 2020
Primary completion
Mar 2023
Modality
Orthosteric Ligands
01

Overview

Randomised, single-blind trial of esmolol in sepsis (2 arms), sponsored by Zhongshan Hospital, Fudan University. Primary endpoint: Resting Energy Expenditure at Day 7. Status: unknown.

02

Drugs

esmolol
03

Conditions

sepsis

Beyond the preview

Go deeper on NCT04537767.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04537767.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call